Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now lists 43 study locations across the United States, United Kingdom, Canada, and Australia, expanding from the previous number of sites. It also shows that results were posted on 2025-12-17.SummaryDifference13%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoval of the government funding status notice banner occurred; core study details, including eligibility criteria and locations, remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedMinor visual and layout adjustments on the Study Details page; core study content, including eligibility criteria, primary outcomes, locations, and enrollment, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedOverall, the page updates its operating status notice and increases the version to v3.2.0, while removing the Huntington disease resource reference and the older v3.1.0 tag.SummaryDifference4%

- Check95 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.